$NMAD 3 SEC Filings

Filed On	Filing
02 Jul 2026	Form 3: Travaglini John Francis, Director No securities owned
01 Jun 2026	Form 3: Porter Stuart D, Director No securities owned
10 Sep 2025	Form 3: Primus Guy Warren, Director No securities owned
04 Sep 2025	Form 3: Stazzone Peter, Chief Financial Officer No securities owned
04 Sep 2025	Form 3: Felix Lourdes, Director No securities owned
21 Jul 2025	Form 3: Holloway Michael Andrew, Director No securities owned
21 Jul 2025	Form 3: Sawyer Jason David, Director No securities owned
18 Jun 2025	Form 3: Pursglove Geordan Garrett, Director No securities owned
01 Aug 2024	Form 3: Schellens Johannes Henricus Matthias, Chief Medical Officer
21 Nov 2022	Form 3: Miser James, Chief Medical Officer
28 Jul 2022	Form 3: Bernards Rene, Director Holds 72,500 shares of Common Stock
18 Jul 2022	Form 3: van der Baan Bastiaan Jeroen, Director Holds 0 shares of Common Stock
06 Apr 2022	Form 3: Krinsky Glenn, 10% owner Holds 141,665 shares of Common Stock
14 May 2021	Form 3: Brown Regina, Director Holds 1,300 shares of Common Stock
20 Aug 2020	Form 3: Weingarten Robert N, Vice President and CFO
11 Dec 2018	Form 3: Greenberg Robert, 10% owner and 2 others Holds 5,650,000 shares of Common Stock
14 Aug 2018	Form 3: Ho Sze Chun Winson, Director
14 Aug 2018	Form 3: Yen Yun, Director
17 Apr 2017	Form 3: Ho Hung Tak, 10% owner Holds 6,000,000 shares of Common Stock
07 Jun 2016	Form 3: Forman Stephen J., Director Holds 22,500 shares of Common Stock

Comments